ags-004

Vaccineexperimental

Clinical trial activity

5 trials · 12 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Sep 1, 2006 (NCT00381212)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ags-004
  • ags-004

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02707900Phase 1Mar 1, 2016National Institute of Allergy and Infectious Diseases (NIAID), University of North Carolina at Chapel Hill
NCT02042248Phase 1Mar 1, 2014Argos Therapeutics, National Institute of Allergy and Infectious Diseases (NIAID), University of North Carolina at Chapel Hill
NCT01069809Phase 2Jul 1, 2010Argos Therapeutics, Drexel University
NCT00672191Phase 2Feb 1, 2008Argos Therapeutics, Clinque Medical du Quartier Latin, Clinque medicale l'Actuel, Hamilton Health Sciences Corporation, Maple Leaf Clinic, McGill University, University of Montreal, University of Ottawa, University of Toronto
NCT00381212Phase 1/Phase 2 (Phase 2)Sep 1, 2006Argos Therapeutics, McGill University, University of Montreal
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (12)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Argos TherapeuticsFor profit4222006
McGill UniversityAcademic/Hospital2112006
National Institute of Allergy and Infectious Diseases (NIAID)Government2012014
University of MontrealAcademic/Hospital2012006
University of North Carolina at Chapel HillAcademic/Hospital2212014
Clinque Medical du Quartier LatinAcademic/Hospital1012008
Clinque medicale l'ActuelAcademic/Hospital1012008
Drexel UniversityAcademic/Hospital1012010
Hamilton Health Sciences CorporationAcademic/Hospital1012008
Maple Leaf ClinicAcademic/Hospital1012008
University of OttawaAcademic/Hospital1012008
University of TorontoAcademic/Hospital1012008
12 organizations
Page 1 / 1